BLT
Click for more information
0.00% 2.6¢ benitec biopharma limited

Whether starting cohort 4 and releasing any and all results data...

  1. aidoaido
    1,366 Posts.
    lightbulb Created with Sketch. 43
    clock Created with Sketch.
    13/11/15
    16:00
    Post #: 16391563
    Whether starting cohort 4 and releasing any and all results data from cohort 3
    is reportable under the ASX continuous disclosure rules may need to be tested
    in law then.
    BLT Price at posting: 36.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

    3. This thread is closed.

    You may not reply to this discussion at this time.

 

Featured News

NEWS What matters for FY25: Investment; interest rates; inflation & elections
right-arrow Created with Sketch.
FWD Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
right-arrow Created with Sketch.
IMM Immutep reports strong response rate from immunotherapies treating carcinomas
right-arrow Created with Sketch.
OBM Ora Banda sees FY26 gold output jumping to 150Koz/pa following key approval for Sand King
right-arrow Created with Sketch.
AUG Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree
right-arrow Created with Sketch.
TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.